COST OF OPIOID USE IN A COMMERCIALLY INSURED POPULATION OF FIBROMYALGIA PATIENTS

被引：0
|
作者：
Juday, T. [1 ]
Blum, S. [1 ]
Erder, M. H. [1 ]
机构：
[1] Forest Res Inst, Jersey City, NJ USA
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)73736-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A134 / A135
页数：2
相关论文
共 50 条
  • [31] Patterns of patient discontinuation from buprenorphine/naloxone treatment for opioid use disorder: A study of a commercially insured population in Massachusetts
    Hasan, Md Mahmudul
    Noor-E-Alam, Md
    Mohite, Prathamesh
    Islam, Md Saiful
    Modestino, Alicia Sasser
    Peckham, Alyssa M.
    Young, Leonard D.
    Young, Gary J.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 131
  • [32] Characterizing the Association Between Traumatic Brain Injury and Discontinuation of Medications for Opioid Use Disorder in a Commercially Insured Adult Population
    Morgan, Jake R.
    Reif, Sharon
    Stewart, Maureen T.
    Larochelle, Marc R.
    Adams, Rachel Sayko
    JOURNAL OF HEAD TRAUMA REHABILITATION, 2025, 40 (02) : E111 - E120
  • [33] Outpatient care for opioid use disorder among the commercially insured: Use of medication and psychosocial treatment
    Busch, Alisa B.
    Greenfield, Shelly F.
    Reif, Sharon
    Normand, Sharon-Lise T.
    Huskamp, Haiden A.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2020, 115
  • [34] Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder
    Tabatabaeepour, Nadia
    Morgan, Jake R.
    Jalali, Ali
    Kapadia, Shashi N.
    Meinhofer, Angelica
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 140
  • [35] PREVALENCE AND COST OF ILLNESS OF SPECIFIC CONDITIONS IN A COMMERCIALLY INSURED UNITED STATES POPULATION
    Eisenberg, D.
    Sanchez, R. J.
    White, T. J.
    VALUE IN HEALTH, 2012, 15 (07) : A519 - A519
  • [36] Cost of Treatment in a US Commercially Insured, HIV-1-Infected Population
    Solem, Caitlyn T.
    Snedecor, Sonya J.
    Khachatryan, Alexandra
    Nedrow, Katherine
    Tawadrous, Margaret
    Chambers, Richard
    Haider, Seema
    Simpson, Kit
    PLOS ONE, 2014, 9 (05):
  • [37] Use Of Oral and Subcutaneous MTX In a Commercially Insured Rheumatoid Arthritis Population
    Curtis, Jeffrey R.
    Xie, Fenglong
    Zhang, Jie
    Chen, Lang
    Yun, Huifeng
    Schiff, Michael H.
    Beukelman, Timothy
    Ginsberg, Seth
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S450 - S450
  • [38] Liraglutide use and evaluation of pancreatic outcomes in a US commercially insured population
    Funch, Donnie
    Mortimer, Kathleen
    Ziyadeh, Najat J.
    Seeger, John D.
    Li, Ling
    Norman, Heather
    Major-Pedersen, Atheline
    Bosch-Traberg, Heidrun
    Gydesen, Helge
    Dore, David D.
    DIABETES OBESITY & METABOLISM, 2019, 21 (08): : 1837 - 1848
  • [39] Prevalence of Nonopioid and Opioid Prescriptions Among Commercially Insured Patients with Chronic Pain
    Miller, Gabrielle F.
    Guy, Gery P.
    Zhang, Kun
    Mikosz, Christina A.
    Xu, Likang
    PAIN MEDICINE, 2019, 20 (10) : 1948 - 1954
  • [40] Query mandates in prescription drug monitoring programs reduce opioid use among commercially insured patients with cancer
    Tham Thi Le
    Fleming, Sean P.
    Kuzucan, Aida
    Dizik, Anna
    Simoni-Wastila, Linda
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2022, 62 (01) : 363 - 369
12345